高雄醫學大學圖書館 |

A Systematic Review: The Use of Botulinum Toxin A for the Treatment of Masseter Hypertrophy and Masticatory Myofascial Pain Associated with Bruxism /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	A Systematic Review: The Use of Botulinum Toxin A for the Treatment of Masseter Hypertrophy and Masticatory Myofascial Pain Associated with Bruxism // Shafia Tariq Khawja.
Author:	Khawja, Shafia Tariq,
Description:	1 electronic resource (55 pages)
Notes:	Source: Masters Abstracts International, Volume: 85-11.
基督教聖經之智慧書導讀 :	Benign masseter hypertrophy causes swelling at the angulus mandibulae and may be associated with masticatory myofascial pain due to hyperfunction from bruxism. The aim of this research was to use the systematic review process to investigate the true or reliable scientific evidence contained in four major databases pertaining to the efficacy and safety of intra-muscular injections of botulinum toxin A (BTX-A) for the treatment of masticatory myofascial pain and benign masseter hypertrophy associated with bruxism, compared with placebo or other traditional treatments prescribed for bruxism such as occlusal splints, pharmacotherapy, or lifestyle modification. Using the PICO format, a research question was formulated, MeSH terms were derived, and an electronic literature search was conducted in PubMed, Embase, Web of Science, and Cochrane. This sequence was followed by a screening and selection of articles by two independent reviewers according to defined inclusion and exclusion criteria. The selected studies were then evaluated and assessed based on study quality and identification of biases, and the results were summarized and reported. This review highlighted the lack of well-designed, randomized controlled trials to evaluate the efficacy and safety of botulinum toxin A for reducing the size/volume of the masseter muscles and for improving masticatory myofascial pain in patients who present with bruxism. Thus, the results were inconclusive.
Contained By:	Masters Abstracts International85-11.
Subject:	Medicine. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31143272
ISBN:	9798382372662

A Systematic Review: The Use of Botulinum Toxin A for the Treatment of Masseter Hypertrophy and Masticatory Myofascial Pain Associated with Bruxism /
Khawja, Shafia Tariq,

A Systematic Review: The Use of Botulinum Toxin A for the Treatment of Masseter Hypertrophy and Masticatory Myofascial Pain Associated with Bruxism /Shafia Tariq Khawja. - 1 electronic resource (55 pages)

Source: Masters Abstracts International, Volume: 85-11.

Benign masseter hypertrophy causes swelling at the angulus mandibulae and may be associated with masticatory myofascial pain due to hyperfunction from bruxism. The aim of this research was to use the systematic review process to investigate the true or reliable scientific evidence contained in four major databases pertaining to the efficacy and safety of intra-muscular injections of botulinum toxin A (BTX-A) for the treatment of masticatory myofascial pain and benign masseter hypertrophy associated with bruxism, compared with placebo or other traditional treatments prescribed for bruxism such as occlusal splints, pharmacotherapy, or lifestyle modification. Using the PICO format, a research question was formulated, MeSH terms were derived, and an electronic literature search was conducted in PubMed, Embase, Web of Science, and Cochrane. This sequence was followed by a screening and selection of articles by two independent reviewers according to defined inclusion and exclusion criteria. The selected studies were then evaluated and assessed based on study quality and identification of biases, and the results were summarized and reported. This review highlighted the lack of well-designed, randomized controlled trials to evaluate the efficacy and safety of botulinum toxin A for reducing the size/volume of the masseter muscles and for improving masticatory myofascial pain in patients who present with bruxism. Thus, the results were inconclusive.

English

ISBN: 9798382372662Subjects--Topical Terms:

219985
Medicine.
Subjects--Index Terms:

Botox

A Systematic Review: The Use of Botulinum Toxin A for the Treatment of Masseter Hypertrophy and Masticatory Myofascial Pain Associated with Bruxism /
LDR:02969nam a22004453i 4500 001 391416
005 20251124054754.5
006 m o d
007 cr|nu||||||||
008 251208s2024 miu||||||m |||||||eng d
020 $a 9798382372662
035 $a (MiAaPQD)AAI31143272
035 $a AAI31143272
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Khawja, Shafia Tariq, $e author. $3 523867
245 1 2 $a A Systematic Review: The Use of Botulinum Toxin A for the Treatment of Masseter Hypertrophy and Masticatory Myofascial Pain Associated with Bruxism / $c Shafia Tariq Khawja.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 1 electronic resource (55 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Masters Abstracts International, Volume: 85-11.
500 $a Advisors: Price, Albert M.; Morin, Sandra.
502 $b M.S.D. $c Boston University $d 2024.
520 $a Benign masseter hypertrophy causes swelling at the angulus mandibulae and may be associated with masticatory myofascial pain due to hyperfunction from bruxism. The aim of this research was to use the systematic review process to investigate the true or reliable scientific evidence contained in four major databases pertaining to the efficacy and safety of intra-muscular injections of botulinum toxin A (BTX-A) for the treatment of masticatory myofascial pain and benign masseter hypertrophy associated with bruxism, compared with placebo or other traditional treatments prescribed for bruxism such as occlusal splints, pharmacotherapy, or lifestyle modification. Using the PICO format, a research question was formulated, MeSH terms were derived, and an electronic literature search was conducted in PubMed, Embase, Web of Science, and Cochrane. This sequence was followed by a screening and selection of articles by two independent reviewers according to defined inclusion and exclusion criteria. The selected studies were then evaluated and assessed based on study quality and identification of biases, and the results were summarized and reported. This review highlighted the lack of well-designed, randomized controlled trials to evaluate the efficacy and safety of botulinum toxin A for reducing the size/volume of the masseter muscles and for improving masticatory myofascial pain in patients who present with bruxism. Thus, the results were inconclusive.
546 $a English
590 $a School code: 0017
650 4 $2 96060 $a Medicine. $3 219985
650 4 $2 96060 $a Aesthetics. $3 251373
650 4 $2 96060 $a Dentistry. $3 184886
653 $a Botox
653 $a Botulinum toxin
653 $a Bruxism
653 $a Masseter hypertrophy
653 $a Myofascial pain
690 $a 0567
690 $a 0650
690 $a 0564
710 2 $a Boston University. $b Periodontology GSDM. $e degree granting institution. $3 523868
720 1 $a Price, Albert M. $e degree supervisor.
720 1 $a Morin, Sandra $e degree supervisor.
773 0 $t Masters Abstracts International $g 85-11.
790 $a 0017
791 $a M.S.D.
792 $a 2024
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31143272